Skip to main content

Atrial Fibrillation - Implications of Basic Research and Novel Curative Approaches Interventional therapy of atrial tachyarrhythmias


Atrial fibrillation is the most common persistent arrhythmia in man. Although atrial fibrillation has a major impact on morbidity and mortality, current treatment focuses on the prevention of embolic events by the use of anticoagulation. Rhythm stabilizing therapy is of modest success. In the last couple of years major progress has been made in the understanding of the pathophysiology of atrial fibrillation.
Catheter ablation, nowadays the preferred treatment for paroxysmal supraventricular tachycardia, has just recently been introduced as a potentially curative therapy for atrial fibrillation. However, many fundamental questions of the pathophysiology of atrial fibrillation and its treatment by catheter ablation, such as the effect of the underlying cardiac disease on the remodelling process or the necessity of anticoagulation after successful catheter ablation, are unsolved.

The three main objectives of the planned conference are:
- Provide a forum for high quality lectures for young investigators given by the leading experts in the field;
- Allow young investigators from Europe to present their latest research to an expert committee;
- Discussion between the scientific expert and the young investigator.
Young investigators will give more than 50% of the oral presentations and will play a major role in the conference. A supplement volume of the European Heart Journal will be edited to support the dissemination of the information provided at the conference.
The Euro conference will be followed by a EuroLab course focussing on catheter ablation of atrial tachyarrhythmias with a special emphasis on atrial fibrillation. Because of the
- high incidence of atrial fibrillation in the general population, it is
- mandatory to spread knowledge on the
- most recent advances how to treat this arrhythmia.
The ablation of a atrial tachyarrhythmias is one of the most fascinating and rapidly progressing research areas in cardiology. The training of young investigators from all parts of Europe will definitely help to establish the leading role of Europe in this field. The planned conference and the course form an excellent basis for young investigators to get high-level scientific information, present their research to the leading scientists and receive practical advise on the latest developments in catheter ablation.

Funding Scheme

ACM - Preparatory, accompanying and support measures


Type of Event: Euro Conference
This Event Takes Place In Tübingen